Cardinal Health Inc (CAH)

CAH on New York Consolidated

91.38USD
24 Apr 2015
Change (% chg)

$-0.12 (-0.13%)
Prev Close
$91.50
Open
$91.41
Day's High
$91.78
Day's Low
$90.90
Volume
1,317,588
Avg. Vol
1,760,739
52-wk High
$91.89
52-wk Low
$63.06

CAH

Chart for CAH

About

Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The Company reports its financial results in two segments: Pharmaceutical and Medical. In the United States, the Pharmaceutical... (more)

Overall

Beta: 0.52
Market Cap(Mil.): $30,167.35
Shares Outstanding(Mil.): 330.13
Dividend: 0.34
Yield (%): 1.50

Financials

  CAH Industry Sector
P/E (TTM): 28.19 28.62 41.83
EPS (TTM): 3.24 -- --
ROI: 9.66 10.17 62.21
ROE: 17.40 11.39 69.64
Search Stocks

Cardinal Health settlement splits FTC along party lines

- The Federal Trade Commission split along political party lines in a deal announced on Monday in which Cardinal Health will pay $26.8 million to settle charges that it illegally monopolized markets in 25 cities for the sale of low-energy radiopharmaceuticals to hospitals and clinics.

21 Apr 2015

In Texas oil town, early signs of economic strain as drilling slows

(This March 29 story corrects to show that sales tax fell for third time since 2010, instead of second time, in first and third paragraphs; and adds graphic)

30 Mar 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters March 03, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, now click on Related Co Data, now click on Co Events.

03 Mar 2015

Cardinal to buy J&J vascular technology unit Cordis for $1.9 billion

NEW YORK - U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9 billion, completing its exit from the cardiovascular stent business.

02 Mar 2015

UPDATE 3-Cardinal to buy J&J vascular technology unit Cordis for $1.9 bln

NEW YORK, March 2 - U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9 billion, completing its exit from the cardiovascular stent business.

02 Mar 2015

Cardinal to buy J&J vascular technology unit Cordis for $1.9 bln

NEW YORK, March 2 - Cardinal Health said on Monday that it would buy Johnson & Johnson's Cordis vascular technology unit for $1.9 billion and that the acquisition would boost 2017 earnings by 20 cents per share.

02 Mar 2015

Whistleblower files U.S. fraud suit against Cardinal Health

- Healthcare services provider Cardinal Health Inc said its unit was accused of fraud and violating U.S. healthcare laws by a whistleblower under the False Claims Act.

03 Feb 2015

Whistleblower files U.S. fraud suit against Cardinal Health

- Healthcare services provider Cardinal Health Inc said its unit was accused of fraud and violating U.S. healthcare laws by a whistleblower under the False Claims Act.

03 Feb 2015

Whistleblower files U.S. fraud suit against Cardinal Health

Feb 3 - Healthcare services provider Cardinal Health Inc said its unit was accused of fraud and violating U.S. healthcare laws by a whistleblower under the False Claims Act.

03 Feb 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks